Hepatobiliary excretion of cysteinyl leukotrienes in three experimental models of acute hepatic injury

Inflammation Research

Volumn 45, Issue 10, 1996, Pages 519-523

  Omar, H M ^a   Sanders, R A ^a   Watkins III, J B ^a  

^a Indiana University School of Medicine   (United States)

Author keywords

Estradiol; Galactosamine; Leukotrienes; Lipopolysaccharide; Streptozotocin

Indexed keywords

ESTRADIOL VALERATE; GALACTOSAMINE; GLUCOSE; LEUKOTRIENE C4; LIPOPOLYSACCHARIDE; PEPTIDOLEUKOTRIENE; STREPTOZOCIN;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE FLOW; BILIARY EXCRETION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; INFLAMMATION; LIVER INJURY; MALE; NONHUMAN; RAT;

ANIMALS; BILE; BODY WEIGHT; ESTRADIOL; LEUKOTRIENE C4; LIPOPOLYSACCHARIDES; LIVER; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 0029800852     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02311089     Document Type: Article

References (46)

1. Krell H. Eicosanoid and bile secretion. In: Siegers CP, Watkins JB III, editors. Biliary Excretion of Drugs and Other Chemicals vol 8/4. Stuttgart: Fischer, 1991:435-54.
2. Richards CD, Gauldie J. Role of cytokines in acute-phase response. In: Aggarwal BB, Puri RK, editors. Human cytokines: their role in disease and therapy. Boston: Blackwell, 1995:253-96.
3. Andus T, Holstege A. Role of cytokines in hepatic and hepatobiliary disease. In: Aggarwal BB, Puri RK, editors. Human cytokines: their role in disease and therapy. Boston: Blackwell, 1995:623-40.
4. Gallin JI, Goldstein IM, Synderman R. Overview. In: Gallin JI, Goldstein IM, Synderman R, editors. Inflammation: basic principles and clinical correlates. New York: Raven Press, 1988:1-3.
5. Hammarstrom W. Leukotrienes. Ann Rev Biochem 1983;52: 355-77.
6. Tiegs G, Wendel A. Leukotriene-mediated liver injury. Biochem Pharmacol 1988;37:2569-73.
7. Hagmann W, Hacker HJ, Buchhalz U. Resident mast cells are the main initiators of anaphylactic leukotriene production in the liver. Hepatology 1992;16:1477-84.
8. Ishikawa T, Muller M, Klunemann C, Schaub T, Keppler D. ATP-dependent primary active transport of cysteinyl leukotriene across liver canalicular membrane. J Biol Chem 1990;265:19279-86.
9. Hagmann W, Parthe S, Kaiser I. Uptake, production and metabolism of cysteinyl leukotrienes in the isolated perfused rat liver: inhibition of leukotriene uptake by cyclosporine. Biochem J 1989;261:611-6.
10. Keppler D, Hagmann W, Rapp S, Denzlinger C, Koch HK. The relation of leukotrienes to liver injury. Hepatology 1985;5:883-91.
11. Decker K. Eicosanoids, signal molecules of liver cells. Semin Liver Dis 1985;5:175-90.
12. Fallon MB, Anderson JM, Boyer JL. Intrahepatic cholestasis. In: Schiff L, Schiff ER, editors. Diseases of the Liver. vol 1. Philadephia: Lippincott, 1993:343-61.
13. Chiou GC, Yao QS, Chang MS, Okawara T. Prevention and treatment of ocular inflammation with a new class of non-steroidal anti-inflammatory agents. J Ocul Pharmacol 1994;10:335-47.
14. Liu P, Fisher MA, Farhood A, Smith CW, Jaeschke H. Beneficial effects of extracellular glutathione against endotoxin-induced liver injury. Circ Shock 1994;43:64-70.
15. Iwai M, Jungermann K. Mechanism of action of cysteinyl leukotrienes on glucose and lactate balance and on flow in perfused rat liver. Eur J Biochem 1989;180:273-81.
16. Kolb H, Kronck KD. Lessons from the low-dose streptozotocin model in mice. Diabet Rev 1993;1:116-26.
17. Burkart V, Kolb H. Protection of islet cells from inflammatory cell death in vitro. Clin Exper Immunol 1993;33:273-8.
18. Watkins JB III, Sanders RA. Diabetes mellitus-induced alterations of hepatobiliary function. Pharmacol Rev 1995;47:1-23.
19. Shiratori Y, Tanaka M, Umihara J, Kawase T, Shiina S, Sugimoto T. Leukotriene inhibitors modulate hepatic injury induced by lipopolysaccharide-activated macrophages. Hepatology 1990;10:51-61.
20. Hagmann W, Denzlinger C, Keppler D. Role of peptide leukotrienes and their hepatobiliary elimination in endotoxin action. Circ Shock 1984;14:223-35.
21. Denzlinger C, Guhlmann A, Scheuber PH, Wilker D, Hammer D, Keppler D. Metabolism and analysis of cysteinyl leukotrienes in the monkey. J Biol Chem 1986;261:15601-6.
22. Reitman S, Frankel S. A colorimetric determination of serum glutamic oxaloacetic and alutamic pyruvic transaminases. Am J Pathol 1957;28:56-63.
23. White WL, Erickson MM, Stevens SC, editors. Chemistry for the Clinical Laboratory. St. Louis: CV Mosby, 1976:228-32.
24. Meister A, Tate SS, Griffith OW. γ-Glutamyltranspeptidase. Meth Enzymol 1981;77:237-53.
25. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker, 1982.
26. Denzlinger C, Rapp S, Hagmann W, Keppler D. Leukotrienes as mediators in tissue trauma. Science 1985;230:330-2.
27. Wettstein M, Gerok W, Haussinger D. Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Eur J Biochem 1989;181:115-24.
28. Watkins JB III, Sherman SE. Long-term diabetes alters the hepatobiliary clearance of acetaminophen, bilirubin and digoxin. J Pharmacol Exp Ther 1992;260:1337-43.
29. Utili R, Abernathy CO, Zimmerman HJ. Cholestatic effects of Escherichia coli endotoxin on the isolated perfused rat liver. Gastroenterol 1976;70:248-53.
30. Tritapepe R, Dipadova C, Rovagnati P. Spontaneous reversal of ethinyl estradiol-induced cholestasis in the rat. Experientia 1980;36:580-1.
31. Roelofsen H, Schoemaker B, Bakker C, Ottenhoff R, Jansen PLM, Oude Elferink RPJ. Impaired hepatocanalicular organic anion transport in endotoxemic rats. Am J Physiol 1995;269:G427-34.
32. Hagmann W, Denzlinger C, Keppler D. Production of peptide leukotrienes in endotoxin shock. FEBS Lett 1985;180:309-13.
33. Meng XJ, Wang JL. Arachidonic acid metabolism in galactosamine, endotoxin. J Tonji Med Univ 1994;14:169-72.
34. 3 in the guinea pig. Identification of metabolites formed by lungs, liver and kidney. J Biol Chem 1981;256:9573-8.
35. 4 synthase. Proc Natl Acad Sci USA 1992;89:11603-6.
36. 4. Prostaglandins 1986;31:239-51.
37. 4 mediates galactosamine endotoxin-induced hepatitis in mice. Biochem Pharmacol 1987;36:1867.
38. 4 disposition and metabolism in the anesthetized and endotoxemic dog. Circ Shock 1991;33:68-83.
39. Huber M, Guhlmann A, Jansen PLM, Keppler D. Hereditary defect of hepatobiliary cysteinyl leukotriene elimination. Hepatology 1987;7:224-8.
40. Denzlinger C, Guhlman A, Hagmann W, Scheuber PH, Scheyerl F, Wilker D, et al. Cysteinyl leukotrienes undergo enterohepatic circulation. Prostagland Leukotr Med 1986;21: 321-2.
41. 4 elimination in isolated perfused rat livers. Biochem Pharmacol 1995;94:297-304.
42. Simon FR, Arias I. Alteration of bile canalicular enzymes in cholestasis. A possible cause of bile secretory failure. J Clin Invest 1973;52:765-75.
43. Smith DJ, Gordon ER. Role of liver plasma membrane fluidity in the pathogenesis of estrogen-induced cholestasis. J Lab Clin Med 1988;112:679-85.
44. Adlercreutz H, Tenhunen R. Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am J Med 1970;49:630-48.
45. Jaeschke H, Trummer E, Krell H. Increase in biliary permeability subsequent to intrahepatic cholestasis by estradiol valerate in rats. Gastroenterology 1987;93:533-8.
46. Kreek MJ. Female sex steroids and cholestasis. Sem Liver Dis 1987;7:8-23.